A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

December 20, 2018

Study Completion Date

December 20, 2018

Conditions
Psoriasis
Interventions
DRUG

Apremilast

Psoriasis patients treated with Otezla® (Apremilast) in Belgium

Trial Locations (22)

1000

CHU St Pierre, Brussels

1020

CHU Brugmann (Victor Horta), Brussels

1070

Clin Univ de Bxl Hôpital Erasme, Brussels

1090

UZ Brussel, Brussels

1200

Cliniques Universitaires St-Luc, Brussels

2440

Private Practice Geel, Geel

2650

UZ Antwerpen, Edegem

3000

UZ Leuven Sint Rafael, Leuven

3600

Private Practice Genk, Genk

4000

CHU Sart-Tilman, Liège

4040

Clinique André Renard d'Herstal, Herstal

4100

CH Bois Abbaye-Hesbaye, Seraing

5000

Private Practice Namur, Namur

Ste Elisabeth - Namur, Namur

5530

CHU UCL Mont-Godinne, Godinne

6280

GHdC - site IMTR, Loverval

7000

Private Practice Mons, Mons

8000

AZ Sint Jan, Bruges

9000

AZ Sint Lucas, Ghent

UZ Gent, Ghent

9340

Private Practice Lede, Lede

9990

Dermatologie Maldegem, Malgegem

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY